Evidence map›Paper›PMID 39803490›Full record

ArticlebioRxiv : the preprint server for biology2025

VISTA-induced tumor suppression by a four amino acid intracellular motif.

Yan Zhao, Tina Andoh, Fatima Charles, Priyanka Reddy, Kristina Paul, Harsh Goar, Ishrat Durdana, Caiden Golder, Ashley Hardy, Marisa M Juntilla and 17 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Yan ZhaoDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Tina AndohDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Fatima CharlesDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Priyanka ReddyDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Kristina PaulDepartments of Genetics, Stanford University, Palo Alto, CA, 94305.
Harsh GoarDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Ishrat DurdanaDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Caiden GolderDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Ashley HardyDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Marisa M JuntillaDepartment Pathology, Stanford University, Palo Alto, CA, 94305.
Soo-Ryum YangDepartment Pathology, Stanford University, Palo Alto, CA, 94305.
Chien-Yu LinDepartment Pathology, Stanford University, Palo Alto, CA, 94305.
Idit Sagiv-BarfiDepartment Medicine, Stanford University, Palo Alto, CA, 94305.
Benjamin S GellerDepartments of Genetics, Stanford University, Palo Alto, CA, 94305.
Stephen MooreDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Dipti ThakkarHummingbird Bioscience, 61 Science Park Road, #06-15/24, Singapore 117525.
Jerome D Boyd-KirkupHummingbird Bioscience, 2450 Holcombe Blvd., Houston, TX, 77021.
Yan PengDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, 75235.
James M FordDepartment Medicine, Stanford University, Palo Alto, CA, 94305.
Melinda L TelliDepartment Medicine, Stanford University, Palo Alto, CA, 94305.
Song ZhangPeter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, 75235.
Allison W KurianDepartment Medicine, Stanford University, Palo Alto, CA, 94305.
Robert B WestDepartment Pathology, Stanford University, Palo Alto, CA, 94305.
Tao YueDepartments of Surgery and Immunology, Center for Organogenesis Research and Trauma, UT Southwestern Medical Center, Dallas, TX 75235.
Andrew M LipchikEugene Applebaum College of Pharmacy and Health Science, Wayne State University, Detroit, MI, 48201.
Michael P SnyderDepartments of Genetics, Stanford University, Palo Alto, CA, 94305.
Joshua J GruberDepartments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
PreCancer Atlas of Familial Adenomatous PolyposisU2CCA233311 · NCI · STANFORD UNIVERSITY · PI SNYDER, MICHAEL P. · 2018 to 2023
$11.6M
Molecular mechanisms and therapeutic principles of VISTA+ triple-negative breast cancersR01CA290297 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI JOSHUA JAMES GRUBER · 2024 to 2026
$1.4M
NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA290297NCI NIH HHS U2C CA233311
6 · The paper itself

Abstract

VISTA is a key immune checkpoint receptor under investigation for cancer immunotherapy; however, its signaling mechanisms remain unclear. Here we identify a conserved four amino acid (NPGF) intracellular motif in VISTA that suppresses cell proliferation by constraining cell-intrinsic growth receptor signaling. The NPGF motif binds to the adapter protein NUMB and recruits Rab11 endosomal recycling machinery. We identify and characterize a class of triple-negative breast cancers with high VISTA expression and low proliferative index. In tumor cells with high VISTA levels, the NPGF motif sequesters NUMB at endosomes, which interferes with epidermal growth factor receptor (EGFR) trafficking and signaling to suppress tumor growth. These effects do not require canonical VISTA ligands, nor a functioning immune system. As a consequence of VISTA expression, EGFR receptor remains abnormally phosphorylated and cannot propagate ligand-induced signaling. Mutation of the VISTA NPGF domain reverts VISTA-induced growth suppression in multiple breast cancer mouse models. These results define a mechanism by which VISTA represses NUMB to control malignant epithelial cell growth and signaling. They also define distinct intracellular residues that are critical for VISTA-induced cell-intrinsic signaling that could be exploited to improve immunotherapy.

Identifiers

PMID39803490
PMCPMC11722267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.